Olga Kromo, M.D.
NPI 1124229091 · Rheumatology Physician · South Miami, FL
Enrolled with Medicare as Practitioner - Rheumatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1124229091
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- TRN8975 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
658 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Administration of Non-Hormonal Anti-Neoplastic Chemotherapy Under Skin Or Into Muscle96401 | 175 | $78 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 132 | $137 |
| Aspiration And/Or Injection of Fluid From Large Joint20610 | 77 | $104 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 62 | $9 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 40 | $15 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 33 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Denosumabbrand: Prolia | 110 | 72 |
| Abatacept/Maltosebrand: Orencia | 79 | 14 |
| Secukinumabbrand: Cosentyx Sensoready (2 Pens) | 53 | — |
| Golimumabbrand: Simponi Aria | 39 | 12 |
| Tramadol Hcl | 37 | — |
| Romosozumab-Aqqgbrand: Evenity (2 Syringes) | 20 | — |
| Tocilizumabbrand: Actemra |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,390 across 202 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2007-05-30
- Last updated
- 2022-07-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.